Guizhou Bailing Group Pharmaceutical: Announcement about the resolution of the tenth meeting of the sixth board of directors.
Guizhou Bailing Group Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Guizhou Bailing Group Pharmaceutical: Announcement regarding the company and related responsible parties receiving the administrative regulatory measures decision.
Guizhou Bailing Group Pharmaceutical: Announcement on the reply to the inquiry letter of 2023 annual report of Shenzhen Stock Exchange.
Guizhou Bailing Group Pharmaceutical: Special Explanation of the Inquiry Letter from Tianjian Certified Public Accountants (Special General Partnership)
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: Legal Opinion (Guizhou Bailing 2023 Annual General Meeting of Shareholders)
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: 002424ST Bering Investor Relations Management Information 20240510
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: Legal Opinion (Guizhou Bailing 2024 Second Extraordinary General Meeting of Shareholders)
Guizhou Bailing Group Pharmaceutical: Announcement on attending the 2024 Guizhou Listed Company Investor Group Reception Day and 2023 Annual Results Briefing
Guizhou Bailing Group Pharmaceutical: 2023 Annual Audit Report
Guizhou Bailing Group Pharmaceutical: Announcement on the renewal of the 2024 financial auditing agency and internal control auditing agency
Guizhou Bailing Group Pharmaceutical: 2023 Independent Director Debriefing Report (Zhang Hongwu)
Guizhou Bailing Group Pharmaceutical: Special note by the board of directors on the 2023 audit report with reservations issued by accounting firms with highlighted sections
Guizhou Bailing Group Pharmaceutical: Annual special audit report on the expenditure of related parties' funds
Guizhou Bailing Group Pharmaceutical: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Guizhou Bailing Group Pharmaceutical: Notice on changes in accounting policies
No Data